The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery
Open accessAbstract
Abstract Lipid nanoparticles (LNPs) are currently the most clinically advanced nonviral carriers for the delivery of small interfering RNA (siRNA). Free siRNA molecules suffer from unfavorable physicochemical characteristics and rapid clearance mechanisms, hampering the ability to reach the cytoplasm of target cells when administered intravenously. As a result, the therapeutic use of siRNA is crucially dependent on delivery strategies. LNPs can encapsulate siRNA to protect it from degradative endonucleases in the circulation, prevent kidney clearance, and provide a vehicle to deliver siRNA in the cell and induce its subsequent release into the cytoplasm. Here, the structure and composition of LNP–siRNA are described including how these affect their pharmacokinetic parameters and gene‐silencing activity. In addition, the evolution of LNP–siRNA production methods is discussed, as the development of rapid‐mixing platforms for the reproducible and scalable manufacturing has facilitated entry of LNP–siRNA into the clinic over the last decade. Finally, the potential of LNPs in delivering other nucleic acids, such as messenger RNA and CRISPR/Cas9 components, is highlighted alongside how a design‐of‐experiment approach may be used to improve the efficacy of LNP formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter contains positively charged ionizable amine groups (at low pH) to interact with the anionic mRNA during particle formation and also facilitate membrane fusion during internalization (Evers et al., 2018, Reichmuth et al., 2016).”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Evers et al., 2018
In the citing paper
“Together with the mRNA, these components form particles of about 60–100 nm in size by using a rapid mixing production technique (Evers et al., 2018).”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Evers et al., 2018
In the citing paper
“Note that the physicochemical and structural characteristics of mRNA LNPs will depend on the lipid composition, the ratio of mRNA to the total amount of (cationic) lipids, and the LNP synthesis (for a detailed review on these parameters also see [107]).”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Chaotic Mixer for Microchannels
Stroock, A. D., Dertinger, S. K. W., Ajdari, A., Mezić, I., Stone, H. A., & Whitesides, G. M. (2002) · Science · doi:10.1126/science.1066238 · Cited by 3,435
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Solvent Compatibility of Poly(dimethylsiloxane)-Based Microfluidic Devices
Lee, J. N., Park, C., & Whitesides, G. M. (2003) · Analytical Chemistry · doi:10.1021/ac0346712 · Cited by 2,643
Szoka, F. C., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,350
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Design and Analysis of Experiments
(2012) · Wiley series in probability and statistics · doi:10.1002/9781118147634 · Cited by 2,042
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Vesicles of variable sizes produced by a rapid extrusion procedure
Mayer, L. D., Hope, M. J., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90302-0 · Cited by 1,693
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes)
Szoka, F. C., & Papahadjopoulos, D. (1980) · Annual Review of Biophysics and Bioengineering · doi:10.1146/annurev.bb.09.060180.002343 · Cited by 1,515
Single bilayer liposomes prepared without sonication
Batzri, S., & Korn, E. D. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90408-2 · Cited by 1,360
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
The function of sterols in membranes
DEMEL, R. A., & Kruyff, B. D. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(76)90008-3 · Cited by 1,347
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 1,211
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,136
Lee, C.-Y., Chang, C. L., Wang, Y.-N., & Fu, L.-M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053263 · Cited by 1,063
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Yin, H., Xue, W., Chen, S., Bogorad, R. L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P. A., Jacks, T., & Anderson, D. G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2884 · Cited by 951
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Hydrodynamic Focusing on a Silicon Chip: Mixing Nanoliters in Microseconds
Knight, J. B., Vishwanath, A., Brody, J. P., & Austin, R. H. (1998) · Physical Review Letters · doi:10.1103/physrevlett.80.3863 · Cited by 888
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 882
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876
Knocking down disease: a progress report on siRNA therapeutics
Wittrup, A., & Lieberman, J. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3978 · Cited by 827
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 807
The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
Farhood, H., Serbina, N. V., & Huang, L. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80016-9 · Cited by 799
Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796
Mishra, S., Webster, P. C., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 740
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 716
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Wittrup, A., Ai, A., Liu, X., Hamar, P., Trifonova, R., Charisse, K., Manoharan, M., Kirchhausen, T., & Lieberman, J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3298 · Cited by 693
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Shen, X., & Corey, D. R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 654
Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642
Novel methods for liposome preparation
Patil, Y. P., & Jadhav, S. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.10.011 · Cited by 640
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520244113 · Cited by 624
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Molecular Basis for Target RNA Recognition and Cleavage by Human RISC
Ameres, S. L., Martînez, J., & Schroeder, R. (2007) · Cell · doi:10.1016/j.cell.2007.04.037 · Cited by 574
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572
Miller, J. B., Zhang, S., Kos, P., Xiong, H., Zhou, K., Perelman, S. S., Zhu, H., & Siegwart, D. J. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610209 · Cited by 540
Controlled Vesicle Self-Assembly in Microfluidic Channels with Hydrodynamic Focusing
Jahn, Α., Vreeland, W. N., Gaitan, M., & Locascio, L. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0318030 · Cited by 539
CRISPR-based adaptive and heritable immunity in prokaryotes
John van der, O. O. S. T., Jore, M. M., Westra, E. R., Lundgren, M., & Brouns, S. J. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.05.002 · Cited by 524
Mui, B. L., Tam, Y. K., Jayaraman, M., Ansell, S. M., Du, X., Tam, Y. Y. C., Lin, P. J. C., Chen, S., Narayanannair, J. K., Rajeev, K. G., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.66 · Cited by 509
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322937111 · Cited by 488
Nanomedicine scale-up technologies: feasibilities and challenges
Paliwal, R., Babu, R. J., & Palakurthi, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0177-9 · Cited by 466
Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 461
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Liposome production by microfluidics: potential and limiting factors
Carugo, D., Bottaro, E., Owen, J., Stride, E., & Nastruzzi, C. (2016) · Scientific Reports · doi:10.1038/srep25876 · Cited by 443
Liposome Technology for Industrial Purposes
Wagner, A., & Vorauer‐Uhl, K. (2010) · Journal of Drug Delivery · doi:10.1155/2011/591325 · Cited by 439
Microfluidic Mixing and the Formation of Nanoscale Lipid Vesicles
Jahn, Α., Stavis, S. M., Hong, J. S., Vreeland, W. N., DeVoe, D. L., & Gaitan, M. (2010) · ACS Nano · doi:10.1021/nn901676x · Cited by 434
Microfluidic Directed Formation of Liposomes of Controlled Size
Jahn, Α., Vreeland, W. N., DeVoe, D. L., Locascio, L. E., & Gaitan, M. (2007) · Langmuir · doi:10.1021/la070051a · Cited by 428
Cullis, P. R., & KRUIJFF, B. D. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90109-8 · Cited by 427
The Condensing Effect of Cholesterol in Lipid Bilayers
Hung, W.-C., Lee, M.-T., Chen, F.-Y., & Huang, H. W. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.099234 · Cited by 424
Gregoriadis, G. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80394-1 · Cited by 424
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 400
Chen, D., Love, K. T., Chen, Y., Eltoukhy, A. A., Kastrup, C. J., Sahay, G., Jeon, A., Dong, Y.-Z., Whitehead, K., & Anderson, D. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301621z · Cited by 386
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
Leung, A. K. K., Tam, Y. Y. C., Chen, S., Hafez, I. M., & Cullis, P. R. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b02891 · Cited by 359
Self-citationPermeability properties of phospholipid membranes: Effect of cholesterol and temperature
Papahadjopoulos, D., Nir, S., & Ohki, S. (1972) · Biochimica et Biophysica Acta · doi:10.1016/0005-2736(72)90354-9 · Cited by 358
The effect of sterol structure on the permeability of lipomes to glucose, glycerol and Rb+
DEMEL, R. A., Bruckdorfer, K. R., & Deenen, L. L. M. V. (1972) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(72)90031-4 · Cited by 357
Pardi, N., Secreto, A. J., Shan, X., Debonera, F., Glover, J., Yi, Y., Muramatsu, H., Ni, H., Mui, B. L., Tam, Y. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14630 · Cited by 352
Liposomes : a practical approach
Torchilin, V. P., & Weissig, V. (2003) · Medical Entomology and Zoology · Cited by 341
Leung, A. K. K., Hafez, I. M., Baoukina, S., Belliveau, N. M., Zhigaltsev, I. V., Afshinmanesh, E., Tieleman, D. P., Hansen, C., Hope, M. J., & Cullis, P. (2012) · The journal of physical chemistry. C, Nanomaterials and interfaces · doi:10.1021/jp303267y · Cited by 339
Zhigaltsev, I. V., Belliveau, N. M., Hafez, I. M., Leung, A. K. K., Huft, J., Hansen, C., & Cullis, P. (2012) · Langmuir · doi:10.1021/la204833h · Cited by 330
Enzyme entrapment in liposomes
Gregoriadis, G. C., Leathwood, P. D., & Ryman, B. E. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80109-6 · Cited by 330
Allen, T. M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90016-7 · Cited by 325
Lipid-based nanovesicles for nanomedicine
Grimaldi, N., Andrade, F., Segovia, N., Ferrer‐Tasies, L., Sala, S., Veciana, J., & Ventosa, N. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00409a · Cited by 315
Sato, Y., Hatakeyama, H., Sakurai, Y., Hyodo, M., Akita, H., & Harashima, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.009 · Cited by 310
A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA
Jeffs, L. B., Palmer, L. R., Ambegia, E. G., Giesbrecht, C., Ewanick, S., & MacLachlan, I. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1873-z · Cited by 307
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619653114 · Cited by 301
Conventional and Dense Gas Techniques for the Production of Liposomes: A Review
Meure, L. A., Foster, N. R., & Dehghani, F. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9097-x · Cited by 299
Influence of Cholesterol on the Association of Plasma Proteins with Liposomes
Semple, S. C., Chonn, A., & Cullis, P. R. (1996) · Biochemistry · doi:10.1021/bi950414i · Cited by 291
Wisse, E., Jacobs, F., Topal, B., Frederik, P. M., & Geest, B. D. (2008) · Gene Therapy · doi:10.1038/gt.2008.60 · Cited by 290
Fenton, O. S., Kauffman, K. J., Kaczmarek, J. C., McClellan, R. L., Jhunjhunwala, S., Tibbitt, M. W., Zeng, M. D., Appel, E. A., Dorkin, J. R., Mir, F. F., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606944 · Cited by 289
Thewalt, J. L., & Bloom, M. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81681-8 · Cited by 279
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 267
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., Gaensler, K. M. L., Tan, X., Dunn, A. L., Kerlin, B. A., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03528 · Cited by 261
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
Fenton, O. S., Kauffman, K. J., McClellan, R. L., Appel, E. A., Dorkin, J. R., Tibbitt, M. W., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2016) · Advanced Materials · doi:10.1002/adma.201505822 · Cited by 252
Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA
Kulkarni, J. A., Myhre, J. L., Chen, S., Tam, Y. Y. C., Danescu, A., Richman, J. M., & Cullis, P. R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.12.014 · Cited by 243
Advances in lipid nanoparticles for siRNA delivery
Tam, Y., Chen, S., & Cullis, P. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030498 · Cited by 229
Self-citationMitosis enhances transgene expression of plasmid delivered by cationic liposomes
Tseng, W., Haselton, F. R., & Giorgio, T. D. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00039-1 · Cited by 221
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209
Buyens, K., Smedt, S. C. D., Braeckmans, K., Demeester, J., Peeters, L., van Grunsven, L. A., du Jeu, X. D. M., Sawant, R. R., Torchilin, V. P., Farkasova, K., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.009 · Cited by 207
Ambegia, E., Ansell, S. M., Cullis, P. R., Heyes, J. A., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 203
Imaging endocytic clathrin structures in living cells
Kirchhausen, T. L. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.09.002 · Cited by 199
Lipid nanoparticle delivery systems for siRNA-based therapeutics
Wan, C. P. L., Allen, T. M., & Cullis, P. R. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0161-z · Cited by 198
Tseng, W.-C., Haselton, F. R., & Giorgio, T. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25641 · Cited by 182
A practical guide to the staggered herringbone mixer
Williams, M. S., Longmuir, K. J., & Yager, P. (2008) · Lab on a Chip · doi:10.1039/b802562b · Cited by 178
Webb, M. S., Saxon, D., Wong, F. M. P., Lim, H. J., Wang, Z., Bally, M. B., Choi, L. S. L., Cullis, P. R., & Mayer, L. D. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00077-7 · Cited by 171
Kastner, E., Kaur, R., Lowry, D., Moghaddam, B., Wilkinson, A. J. K., & Perrie, Y. (2014) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2014.10.030 · Cited by 169
Systemic and Specific Delivery of Small Interfering RNAs to the Liver Mediated by Apolipoprotein A-I
Kim, S. I., Shin, D., Choi, T. H., Lee, J. C., Cheon, G. J., Kim, K.-Y., Park, M., & Kim, M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300168 · Cited by 169
Andar, A. U., Hood, R. R., Vreeland, W. N., DeVoe, D. L., & Swaan, P. W. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1171-8 · Cited by 166
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Leung, A. K. K., Tam, Y. K., & Cullis, P. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.025 · Cited by 160
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Hood, R. R., & DeVoe, D. L. (2015) · Small · doi:10.1002/smll.201501345 · Cited by 156
The effect of ultrasonic irradiation on the chemical structure of egg lecithin
Hauser, H. (1971) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(71)90443-8 · Cited by 154
Kirby, C. J., Clarke, J., & Gregoriadis, G. C. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80819-2 · Cited by 125
From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010
Deamer, D. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-0503 · Cited by 125
THE CROSSFLOW INJECTION TECHNIQUE: AN IMPROVEMENT OF THE ETHANOL INJECTION METHOD
Wagner, A., Vorauer‐Uhl, K., Kreismayr, G., & Katinger, H. W. D. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120014761 · Cited by 122
Correia, M. G. S., Briuglia, M. L., Niosi, F., & Lamprou, D. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.025 · Cited by 118
Characterization of liposomes prepared using a microemulsifier
Mayhew, E. G., Lazo, R. O., Vail, W. J., King, J., & Green, A. M. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90167-6 · Cited by 116
Hope, M. J., Mui, B. L., Ansell, S. M., & AHKONG, Q. F. (1998) · Molecular Membrane Biology · doi:10.3109/09687689809027512 · Cited by 112
Liposomes and Other Vesicular Systems
Elizondo, E., Moreno, E., Cabrera, I., Córdoba, A., Sala, S., Veciana, J., & Ventosa, N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00001-2 · Cited by 107
Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes
Bao, Y., Jin, Y., Chivukula, P., Zhang, J., Liu, Y., Liu, J., Clamme, J., Mahato, R. I., Ng, D., Ying, W., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0874-6 · Cited by 107
Biodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo
Zhang, X., Li, B., Luo, X., Zhao, W., Jiang, J., Zhang, C., Gao, M., Chen, X., & Dong, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08163 · Cited by 107
Liposomes in Drug Delivery: How It All Happened
Gregoriadis, G. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020019 · Cited by 98
Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles
Crawford, R., Dogdas, B., Keough, E., Haas, R. M., Wepukhulu, W., Krotzer, S., Burke, P. A., Sepp‐Lorenzino, L., Bagchi, A., & Howell, B. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.025 · Cited by 96
Mok, K. W. C., Lam, A. M. I., & Cullis, P. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00059-0 · Cited by 96
Flow regimes in T-shaped micro-mixers
Andreussi, T., Galletti, C., Mauri, R., Camarri, S., & Salvetti, M. V. (2015) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2015.02.017 · Cited by 83
Microfluidic self-assembly of folate-targeted monomolecular siRNA-lipid nanoparticles
Krzysztoń, R., Salem, B., Lee, D.-J., Schwake, G., Wagner, E., & Rädler, J. O. (2017) · Nanoscale · doi:10.1039/c7nr01593c · Cited by 82
Michelon, M., de Oliveira, D. R. B., Furtado, G. D. F., de la Torre, L. G., & Cunha, R. L. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.05.033 · Cited by 80
Liposomal targeting and drug delivery: kinetic consideration
Harashima, H., & Kiwada, H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00012-9 · Cited by 76
Microfluidics: a transformational tool for nanomedicine development and production
Garg, S., Heuck, G., Ip, S. Y., & Ramsay, E. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1198354 · Cited by 76
Cern, A., Marcus, D., Tropsha, A., Barenholz, Y., & Goldblum, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.015 · Cited by 68
Yamamoto, N., Sato, Y., Munakata, T., Kakuni, M., Tateno, C., Sanada, T., Hirata, Y., Murakami, S., Tanaka, Y., Chayama, K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.014 · Cited by 67
Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles
Kulkarni, J. A., Tam, Y. Y. C., Chen, S., Tam, Y. K., Zaifman, J., Cullis, P. R., & Biswas, S. (2017) · Nanoscale · doi:10.1039/c7nr03272b · Cited by 66
CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
Blenke, E. O., Evers, M. J. W., Mastrobattista, E., & John van der, O. O. S. T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.002 · Cited by 63
Lee, J. B., Zhang, K., Tam, Y. Y. C., Quick, J., Tam, Y. K., Lin, P. J. C., Chen, S., Liu, Y., Nair, J. K., Zlatev, I., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.43 · Cited by 61
Elucidating the Encapsulation of Short Interfering RNA in PEGylated Cationic Liposomes
Buyens, K., Demeester, J., Smedt, S. C. D., & Sanders, N. N. (2009) · Langmuir · doi:10.1021/la803973p · Cited by 57
Simple Mixing Device to Reproducibly Prepare Cationic Lipid-DNA Complexes (Lipoplexes)
Hirota, S., de Ilarduya, C. T., Barron, L. G., & Szoka, F. C. (1999) · BioTechniques · doi:10.2144/99272bm16 · Cited by 56
Microfluidic-Based Manufacture of siRNA-Lipid Nanoparticles for Therapeutic Applications
Walsh, C., Ou, K., Belliveau, N. M., Leaver, T., Wild, A., Huft, J., Lin, P. J. C., Chen, S., Leung, A. K. K., Lee, J. B., et al. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0363-4_6 · Cited by 55
Introduction to Special Issue: A New Paradigm of Gene Therapy
Itaka, K. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8010001 · Cited by 50
Jahn, Α., Lucas, F., Wepf, R. A., & Dittrich, P. S. (2013) · Langmuir · doi:10.1021/la303675g · Cited by 50
Rodrigueza, W. V., Wheeler, J. J., Klimuk, S. K., Kitson, C. N., & Hope, M. J. (1995) · Biochemistry · doi:10.1021/bi00018a025 · Cited by 48
The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo
Rodrigueza, W. V., Pritchard, P. H., & Hope, M. J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90270-a · Cited by 46
Recent Progress in Liposome Production, Relevance to Drug Delivery and Nanomedicine
Koynova, R. D., & Tenchov, B. G. (2015) · Recent Patents on Nanotechnology · doi:10.2174/187221050902150819151721 · Cited by 43
Zhigaltsev, I. V., Tam, Y. K., Leung, A. K. K., & Cullis, P. R. (2015) · Journal of Liposome Research · doi:10.3109/08982104.2015.1025411 · Cited by 38
Entrapment of ribonucleic acids in liposomes
Dimitriadis, G. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80582-1 · Cited by 34
(2014) · Nature Biotechnology · doi:10.1038/nbt.3045 · Cited by 33
Progress towards a synthetic virus for systemic gene therapy.
MacLachlan, I., Cullis, P. R., & Graham, R. W. (1999) · PubMed · Cited by 32
A Novel Mixing Device for the Reproducible Generation of Nonviral Gene Therapy Formulations
Davies, L. A., Nunez-Alonso, G. A., Hebel, H. L., Scheule, R., Cheng, S. H., Hyde, S. C., & Gill, D. R. (2010) · BioTechniques · doi:10.2144/000113498 · Cited by 16
Stacking up CRISPR against RNA i for therapeutic gene inhibition
Haussecker, D. (2016) · FEBS Journal · doi:10.1111/febs.13742 · Cited by 16
Flagged first, then by citations
Research works printed but not linked: 5
- Leung A. K. K., 2015, Ph.D. Thesis
- Mozafari M. R., 2010, Liposomes, Method in Molecular Biology (Methods and Protocols)
- Walsh C., 2014, Drug Delivery Systems, 109
- Hope M., 1993, Liposome Technology, 123
- MacLachlan I., 1999, Curr. Opin. Mol. Ther., 1, 252
Cited by
Sorted by citations
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
“The latter contains positively charged ionizable amine groups (at low pH) to interact with the anionic mRNA during particle formation and also facilitate membrane fusion during internalization (Evers et al., 2018; Reichmuth et al., 2016).”
Self-citationmRNA vaccine for cancer immunotherapy
Miao, L., Zhang, Y., & Huang, L. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01335-5 · Cited by 966
Chemistry of Lipid Nanoparticles for RNA Delivery
Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00544 · Cited by 917
Nanomaterial Delivery Systems for mRNA Vaccines
Buschmann, M. D., Carrasco, M. J., Alishetty, S., Paige, M., Alameh, M. G., & Weissman, D. (2021) · Vaccines · doi:10.3390/vaccines9010065 · Cited by 582
“Prior methods, such as thin film hydration and ethanol injection, are generally not used since they result in heterogeneous larger-sized nanoparticles with lower mRNA encapsulation efficiency, which are difficult to scale up [95].”
BackgroundMethod
Metadata
- Authors
- Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M.
- Affiliations
- University Medical Center Utrecht (NL)
- University of British Columbia (CA)
- Department of Clinical Chemistry and Haematology University Medical Center Utrecht Heidelberglaan 100 3584 CX Utrecht The Netherlands
- Corresponding author
- Schiffelers, Raymond M.
- Venue
- Small Methods
- Publisher
- Wiley
- Published
- 2018-04-26
- Volume
- 2
- Issue
- 9
- ISSN
- 2366-9608 (ISSN-L)
- OpenAlex
- W2799813152
- Cited by
- 332
- References
- 153
- Citations by year
- 2026: 52 · 2025: 55 · 2024: 56 · 2023: 58 · 2022: 52 · 2021: 32 · 2020: 15 · 2019: 9 · 2018: 2
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- Locations
- Small Methods (publishedVersion, public-domain)
- TU/e Research Portal (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- H2020 LEIT Nanotechnologies (721058, # 14385, # 13667)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Canadian Institutes of Health Research (148469)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- lipid nanoparticles, siRNA delivery, non-viral gene delivery, pharmacokinetics, gene silencing, mRNA delivery, CRISPR/Cas9 delivery, scalable fabrication, experimental design, nucleic acid carriers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review